09/15/20 8:00 AMNasdaq : GENEGenetic Technologies Provides Update on COVID-19 Disease Severity Test DevelopmentMolecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ:GENE) ("Genetic Technologies" or the "Company") is developing a Polygenic Risk Score (PRS) test for COVID-19 which may enable an assessment of risk of anRHEA-AIneutral
09/11/20 8:33 AMNasdaq : GENEGenetic Technologies Announces US Sales Have Commenced via Online Health PlatformMolecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, "Company") is delighted to announce that initial sales of its GeneType for Breast Cancer Risk Assessment have now commenced in the United States via an onlineRHEA-AIneutral
09/01/20 4:45 PMNasdaq : GENEGenetic Technologies Regains Compliance with Nasdaq Stockholders Equity RequirementGenetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the "Company"), a leader in the development of genetic risk assessment tests, is pleased to announce that it received notification from the Listing Qualifications Department ofRHEA-AIneutral
